Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Ascletis Announces IND Approval of Viral Polymerase Inhibitor ASC10 for Monkeypox Indication by U.S. FDA
2022-11-16 08:10
Innovent Announces First Participant Dosed in a Phase 3 Clinical Study (GLORY-1) of Mazdutide (IBI362) in Chinese Adults with Overweight or Obesity
2022-11-15 08:00
Everest Medicines Announces New Drug Application Acceptance by China NMPA for Nefecon for the Treatment of Primary IgA Nephropathy
2022-11-15 08:00
RedHill Accelerates Opaganib's Nuclear Radiation Protection Program - Positive Data Published
2022-11-14 20:06
TauRx Announces Additional Investment of USD119 million following announcement of Phase 3 LUCIDITY Topline Results
2022-11-14 15:00
Innovent Presents Clinical Data of Phase Ia Study for IBI351 (KRAS G12C Inhibitor) as Monotherapy for Solid Tumors at the 2022 Chinese Society of Clinical Oncology (CSCO) Annual Meeting
2022-11-14 08:00
Telix to Present at Jefferies London Healthcare Conference 2022
2022-11-11 20:00
Winning the Fight Against Neuropathy in Diabetic Patients
2022-11-11 17:44
LOTUS REPORTS ITS BEST QUARTER EVER WITH THE BIGGEST LAUNCH IN ITS HISTORY
2022-11-11 17:00
Bridgewest Group inks deal with Pfizer to acquire injectable manufacturing plant in Western Australia
2022-11-11 10:07
Transcenta Presented Two Scientific Posters at SITC 2022 Annual Meeting
2022-11-11 08:00
YS Biopharma Announces US FDA Clearance Of IND Application For PIKA COVID-19 vaccine
2022-11-10 22:30
Novo Nordisk earns the Best Place to Work Certification in Pakistan for 2022
2022-11-10 21:56
Prenetics Announces Record Third Quarter 2022 Financial Results and Raises Full Year 2022 Revenue and EBITDA Guidance
2022-11-10 21:30
Medison Pharma Announces Expansion of the Multi-Territorial Agreement with Immunocore into Latin America
2022-11-09 23:32
Transcenta to Hold 3 Exchange Sessions on Post-SITC Business Update Call & TST003 data release and pipeline development progress update
2022-11-09 21:09
JW Therapeutics Announces its Cell Immunotherapy Drugs Have Successfully Benefited 300 Patients
2022-11-09 17:00
Siemens Healthineers to demonstrate the remote capabilities of Corindus CorPath GRX Robotic System using Mentice VIST ® Simulator
2022-11-09 16:52
TES Pharma Congratulates Intercept Pharmaceuticals on their Presentation of Phase 1 INT-787 Data at the AASLD Meeting and the Initiation of the Phase 2a FRESH Study in Patients with Severe Alcohol-Associated Hepatitis
2022-11-09 06:00
Himalaya Therapeutics Announces Highlights of Recent Clinical Progress
2022-11-08 23:08
1
55
56
57
58
59
230